Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B
0.1.0 - STU International flag

Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B - Downloaded Version null See the Directory of published versions

CodeSystem: v3-substanceAdminSubstitution

Official URL: http://hl7.org/fhir/v3/substanceAdminSubstitution Version: 1.0.2
Standards status: Trial-use Maturity Level: 0 Computable Name: v3-substanceAdminSubstitution

This Code system is referenced in the content logical definition of the following value sets:

Properties

This code system defines the following properties for its concepts

NameCodeURIType
status status http://hl7.org/fhir/concept-properties#status code
Inactive inactive http://hl7.org/fhir/concept-properties#inactive boolean
effectiveDate effectiveDate http://hl7.org/fhir/concept-properties#effectiveDate dateTime
deprecationDate deprecationDate http://hl7.org/fhir/concept-properties#deprecationDate dateTime
retirementDate retirementDate http://hl7.org/fhir/concept-properties#retirementDate dateTime
Not Selectable notSelectable http://hl7.org/fhir/concept-properties#notSelectable boolean
Parent parent http://hl7.org/fhir/concept-properties#parent code
Child child http://hl7.org/fhir/concept-properties#child code
partOf partOf http://hl7.org/fhir/concept-properties#partOf code
synonym synonym http://hl7.org/fhir/concept-properties#synonym code
comment comment http://hl7.org/fhir/concept-properties#comment string
itemWeight itemWeight http://hl7.org/fhir/concept-properties#itemWeight decimal

Concepts

This case-sensitive code system http://hl7.org/fhir/v3/substanceAdminSubstitution defines the following codes in an undefined hierarchy:

LvlCodeDisplayDefinitionNot Selectable
1 _ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. true
2   E equivalent Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. false
3     EC equivalent composition Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril false
4       BC brand composition Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven false
4       G generic composition Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) false
3     TE therapeutic alternative Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet false
4       TB therapeutic brand Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet false
4       TG therapeutic generic Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine false
2   F formulary Description: This substitution was performed or is permitted based on formulary guidelines. false
2   N none No substitution occurred or is permitted. false